However, it is not known how bacterial amyloids interact with other pathological processes in Alzheimer’s disease, such as tau protein dysfunction, neuroinflammation and cerebrovascular degeneration. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.